HARMON CYRUS (Chief Technology Officer) sold 0.4% of their position (2.88K shares) of OLEMA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $82.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/29/2025ACC: 0001831410-25-000007
DirectorOfficer· Chief Technology Officer
Since Nov 2020
-2.88K
Net shares
Net seller
$82.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.88K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.88K
Price / share
$28.53
Trade value
$82.19K
% of position
0.4%
12/22/2025
744.14K→741.26K
Total
Net shares
−2.88K
Net value
-$82.19K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/22/2025 | S · Sale | −2.88K | $28.53 | $82.19K | 0.4% | 744.14K | 741.26K |
| Total | −2.88K | -$82.19K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned117.03K
Total
117.03K indirect117.03K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 117.03K | Indirect |
| Total | 117.03K | 117.03K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported